YU29802A - Novi oligosaharidi, njihova proizvodnja i farmaceutske kompozicije sa sadržajem istih - Google Patents

Novi oligosaharidi, njihova proizvodnja i farmaceutske kompozicije sa sadržajem istih

Info

Publication number
YU29802A
YU29802A YU29802A YUP29802A YU29802A YU 29802 A YU29802 A YU 29802A YU 29802 A YU29802 A YU 29802A YU P29802 A YUP29802 A YU P29802A YU 29802 A YU29802 A YU 29802A
Authority
YU
Yugoslavia
Prior art keywords
pharmaceutical compositions
compositions containing
preparation
containing same
novel oligosaccharides
Prior art date
Application number
YU29802A
Other languages
English (en)
Inventor
Pierre Mourier
Elisabeth Perrin
Christian Viskov
Jean-Marie Stutzmann
Florence Chez M. Karoby WAHL
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of YU29802A publication Critical patent/YU29802A/sh
Publication of RS50829B publication Critical patent/RS50829B/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Virology (AREA)
  • Psychology (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Vascular Medicine (AREA)
  • Communicable Diseases (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Tropical Medicine & Parasitology (AREA)

Abstract

Ovaj pronalazak se odnosi na oligosaharide formule: njihove mešavine, njihove diastereoizomere, postupak za njihovu proizvodnju i farmaceutske kompozicije sa sadržajem istih.[The invention concerns oligosaccharides of formula (I), their mixtures, their diastereomers, methods for preparing them and pharmaceutical compositions containing them.
YUP-298/02A 1999-10-22 2000-10-18 Novi oligosaharidi, njihova proizvodnja i farmaceutske kompozicije sa sadržajem istih RS50829B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9913182A FR2800074B1 (fr) 1999-10-22 1999-10-22 Nouveaux oligosaccharides, leur preparation et les compositions pharmaceutiques les contenant

Publications (2)

Publication Number Publication Date
YU29802A true YU29802A (sh) 2006-01-16
RS50829B RS50829B (sr) 2010-08-31

Family

ID=9551218

Country Status (31)

Country Link
EP (1) EP1226148B1 (sh)
JP (1) JP4733329B2 (sh)
KR (2) KR100872215B1 (sh)
CN (1) CN1241932C (sh)
AT (1) ATE534656T1 (sh)
AU (1) AU781414B2 (sh)
BR (1) BR0014939A (sh)
CA (1) CA2388369C (sh)
CY (1) CY1112274T1 (sh)
CZ (1) CZ303255B6 (sh)
DK (1) DK1226148T3 (sh)
EA (1) EA004046B1 (sh)
EE (1) EE05091B1 (sh)
ES (1) ES2376409T3 (sh)
FR (1) FR2800074B1 (sh)
HK (1) HK1050535A1 (sh)
HR (1) HRP20020330A2 (sh)
HU (1) HU229385B1 (sh)
IL (2) IL149154A0 (sh)
ME (1) MEP9309A (sh)
MX (1) MXPA02003945A (sh)
NO (1) NO323409B1 (sh)
NZ (1) NZ518539A (sh)
PL (1) PL204623B1 (sh)
PT (1) PT1226148E (sh)
RS (1) RS50829B (sh)
SK (1) SK287459B6 (sh)
TR (1) TR200201102T2 (sh)
UA (1) UA72545C2 (sh)
WO (1) WO2001029055A2 (sh)
ZA (1) ZA200203102B (sh)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4676048B2 (ja) * 2000-07-10 2011-04-27 生化学工業株式会社 脱髄性疾患処置剤
ATE290874T1 (de) * 2000-12-16 2005-04-15 Aventis Pharma Gmbh Verwendung von niedermolekularen heparin zur behandlung von osteoarthrose
DE10121003A1 (de) 2001-04-28 2002-12-19 Aventis Pharma Gmbh Anthranilsäureamide, Verfahren zur Herstellung, ihrer Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
EP2284535A1 (en) 2002-03-11 2011-02-16 Momenta Pharmaceuticals, Inc. Low molecular weight heparins
FR2844808B1 (fr) * 2002-09-23 2005-02-25 Aventis Pharma Sa Methode de determination de groupements specifiques constituant les heparines ou les heparines de bas poids moleculaire
US20040171819A1 (en) 2002-10-10 2004-09-02 Aventis Pharma S.A. Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
US7511026B2 (en) * 2003-03-25 2009-03-31 Seikagaku Corporation Therapeutic agent for nerve damage
FR2857971B1 (fr) * 2003-07-24 2005-08-26 Aventis Pharma Sa Melanges d'oligosaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
US7956046B2 (en) * 2003-07-24 2011-06-07 Aventis Pharma S.A. Oligosaccharide mixtures derived from heparin, preparation thereof and pharmaceutical compositions containing them
US20050186679A1 (en) * 2004-02-24 2005-08-25 Christian Viskov Method for determining specific groups constituting heparins or low molecular weight heparins
EP1580197A1 (en) * 2004-03-24 2005-09-28 Aventis Pharma S.A. Method for quantitatively determining specific groups constituting heparins or low molecular wieght heparins using HPLC
EP1582531A1 (en) 2004-03-24 2005-10-05 Aventis Pharma S.A. Process for oxidizing unfractionated heparins and detecting presence or absence of glycoserine in heparin and heparin products
DE102005017799A1 (de) * 2005-04-18 2006-10-19 Abbott Gmbh & Co. Kg Verwendung von Heparin und Heparinderivaten zur Modulation des Neuritenwachstum-kontrollierenden Nogo-Rezeptors
US8101733B1 (en) 2006-06-27 2012-01-24 Momenta Pharmaceuticals, Inc. Methods of evaluating mixtures of polysaccharides
US7790466B1 (en) 2007-01-26 2010-09-07 Momenta Pharmaceuticals, Inc. Evaluating mixtures of low molecular weight heparins by chain profiles or chain mapping
US7968082B1 (en) 2007-01-26 2011-06-28 Momenta Pharmaceuticals, Inc. Evaluating mixtures of low molecular weight heparins by NMR
US9139876B1 (en) 2007-05-03 2015-09-22 Momenta Pharmacueticals, Inc. Method of analyzing a preparation of a low molecular weight heparin
EP2256138A1 (en) * 2009-05-05 2010-12-01 Sanofi-Aventis Novel acylated 1,6-anhhydro decasaccharide and its use as antithrombotic agent
FR2949114B1 (fr) * 2009-08-14 2011-08-26 Sanofi Aventis OCTASACCHARIDES N-ACYLES ACTIVATEURS DES RECEPTEURS DES FGFs, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2949115B1 (fr) * 2009-08-14 2012-11-02 Sanofi Aventis OLIGOSACCHARIDES N-SULFATES ACTIVATEURS DES RECEPTEURS DES FGFs, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
CN102791742B (zh) 2010-01-19 2014-12-24 动量制药公司 评价肝素制剂
WO2012115952A1 (en) 2011-02-21 2012-08-30 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations
CN102864191A (zh) * 2011-12-16 2013-01-09 深圳市海普瑞药业股份有限公司 肝素双糖混合物及其制备方法和应用
CN104910217B (zh) * 2015-06-19 2018-04-17 天津红日药业股份有限公司 用于磺达肝癸钠质量控制的参比化合物
CZ308106B6 (cs) * 2016-06-27 2020-01-08 Contipro A.S. Nenasycené deriváty polysacharidů, způsob jejich přípravy a jejich použití
CN110092848A (zh) * 2019-05-14 2019-08-06 山东辰龙药业有限公司 一种贝米肝素钠的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2519987A1 (fr) * 1982-01-15 1983-07-22 Choay Sa Trisaccharides a structures d-glucosamine, acide d-glucuronique, d-glucosamine et leur preparation
AU563351C (en) * 1982-01-15 2003-06-19 Glaxo Group Limited Synthesis of oligosaccharides
FR2764511B1 (fr) * 1997-06-13 2000-09-08 Sanofi Sa Compositions pour le traitement et la prevention de la thrombose arterielle et utilisation d'un inhibiteur du facteur xa seul et/ou en combinaison avec un antiagregant plaquettaire
JP4166851B2 (ja) * 1997-09-29 2008-10-15 生化学工業株式会社 新規虚血・再灌流障害抑制剤

Also Published As

Publication number Publication date
TR200201102T2 (tr) 2002-12-23
HRP20020330B1 (sh) 2013-01-31
IL149154A0 (en) 2002-11-10
CZ303255B6 (cs) 2012-06-27
CZ20021385A3 (cs) 2002-07-17
SK287459B6 (sk) 2010-10-07
HU229385B1 (en) 2013-11-28
EA200200479A1 (ru) 2002-10-31
EE05091B1 (et) 2008-10-15
PL204623B1 (pl) 2010-01-29
MXPA02003945A (es) 2002-10-23
CN1241932C (zh) 2006-02-15
CN1379781A (zh) 2002-11-13
IL149154A (en) 2008-04-13
EE200200208A (et) 2003-06-16
HUP0203821A2 (hu) 2003-04-28
KR100872215B1 (ko) 2008-12-05
WO2001029055A2 (fr) 2001-04-26
KR20070087263A (ko) 2007-08-27
CY1112274T1 (el) 2015-12-09
UA72545C2 (uk) 2005-03-15
HRP20020330A2 (en) 2004-04-30
PT1226148E (pt) 2012-01-24
MEP9309A (en) 2011-12-20
DK1226148T3 (da) 2012-03-19
ATE534656T1 (de) 2011-12-15
JP2003512385A (ja) 2003-04-02
NO323409B1 (no) 2007-04-30
NO20021859D0 (no) 2002-04-19
RS50829B (sr) 2010-08-31
ZA200203102B (en) 2003-09-23
EP1226148A2 (fr) 2002-07-31
NZ518539A (en) 2004-10-29
EP1226148B1 (fr) 2011-11-23
KR20020063881A (ko) 2002-08-05
ES2376409T3 (es) 2012-03-13
FR2800074B1 (fr) 2001-12-21
CA2388369C (fr) 2011-02-01
SK5272002A3 (en) 2002-08-06
FR2800074A1 (fr) 2001-04-27
CA2388369A1 (fr) 2001-04-26
BR0014939A (pt) 2002-06-18
WO2001029055A3 (fr) 2002-02-14
HK1050535A1 (en) 2003-06-27
NO20021859L (no) 2002-06-13
AU781414B2 (en) 2005-05-19
JP4733329B2 (ja) 2011-07-27
PL363052A1 (en) 2004-11-15
HUP0203821A3 (en) 2003-10-28
KR100778166B1 (ko) 2007-11-27
EA004046B1 (ru) 2003-12-25
AU7930200A (en) 2001-04-30

Similar Documents

Publication Publication Date Title
IL149154A0 (en) Novel oligosaccharides, preparation method and pharmaceutical compositions containing same
DE60112609D1 (en) Pyrazolopyridine
DE69726577D1 (en) Kristallin form i von clarithromycin
PL366198A1 (en) Novel compounds
HK1048990A1 (en) Novel compounds.
DE60116761D1 (en) Adamantanderivate
AU2002305143A1 (en) Pyrazolo'1,5-a!pyridine derivatives
AP2002002458A0 (en) Compounds for the treatment of ischemia.
SE9901875D0 (sv) Novel compounds
HK1031869A1 (en) 1-Ä(1-Substituted-4-piperidinyl)methylÜ-4-piperdine derivatives, process for producing the same, medicinal compositions containing the same and intermediates of these compounds.
HUP0103913A3 (en) Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same
DE60112330D1 (en) Pyrazolopyridinderivate
HK1030218A1 (en) Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and compositions containing same.
IL117091A0 (en) Methylphenyloxazolidinone derivatives pharmaceutical compositions containing the same and processes for the preparation thereof
MXPA03001536A (es) (aminoalcoxibenzoil) benzofuranos o benzotiofenos, metodo para preparar los mismo y composiciones que los contienen.
NZ515108A (en) Novel ribose-substituted aromatic amides, method for the production and use thereof as medicaments
YU10599A (sh) Amorfni benzotiofeni, postupak dobijanja istih i njihova farmaceutska formulacija
YU72802A (sh) Farmaceutske smeše koje sadrže oligosaharide, novi oligosaharidi i njihovo dobijanje
AU2002248531A1 (en) Pyrazolopyriadine derivatives
AU2002357740A1 (en) Pyrazolo-pyridine derivatives as antiherpes agents
SE9904128D0 (sv) Novel compounds
EP1132383A4 (en) NEW AGAROFURAN DERIVATIVES, THEIR PRODUCTION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USE AS MEDICINE
MXPA03010259A (es) Nuevos derivados de 5-tio-ss-d-xilopiranosida, procedimiento de preparacion, composiciones farmaceuticas que los contienen y el uso terapeutico de los mismos.
CA2420056A1 (en) 1-amino-alkylcyclohexanes as trypanocidal agents
PL332480A1 (en) Novel heteroaruylooxyethylamines, method of obtaining them, their application as drugs as well as pharmaceutic compositions containing them